| 000 | 01689 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513200245.0 | ||
| 264 | 0 | _c20000124 | |
| 008 | 200001s 0 0 eng d | ||
| 022 | _a0169-5002 | ||
| 024 | 7 |
_a10.1016/s0169-5002(99)00089-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaohavinij, S | |
| 245 | 0 | 0 |
_aPhase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer. _h[electronic resource] |
| 260 |
_bLung cancer (Amsterdam, Netherlands) _cDec 1999 |
||
| 300 |
_a175-85 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aMaoleekoonpairoj, S | |
| 700 | 1 | _aCheirsilpa, A | |
| 700 | 1 | _aManeechavakajorn, J | |
| 700 | 1 | _aSirachainant, E | |
| 700 | 1 | _aArpornvivat, W | |
| 700 | 1 | _aJaisathaporn, K | |
| 700 | 1 | _aRatanatharathorn, V | |
| 773 | 0 |
_tLung cancer (Amsterdam, Netherlands) _gvol. 26 _gno. 3 _gp. 175-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0169-5002(99)00089-6 _zAvailable from publisher's website |
| 999 |
_c10554997 _d10554997 |
||